FDA Inspection 1177374 — Azidus Laboratories Limited
The FDA completed an inspection of Azidus Laboratories Limited on July 15, 2022 in Chennai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chennai (India)
Additional Details
Clinical BA/BE